Greater Glasgow and Clyde Medicines

MHRA Drug Safety Update September 2022

NHS Public Health Scotland advise giving paracetamol suspension 120mg/5ml (sugar free) at the time of MenB vaccination, or as soon as possible afterwards, in order to reduce the risk of the baby developing a fever.

• Sodium hyaluronate eye drops are on the NHSGGC Adult Medicines Formulary restricted to use in severe dry eye only

• Blink Intensive Tears® (sodium hyaluronate 0.2%) eye drops (containing a preservative) are considered the first line sodium hyaluronate preparation.

• Eyeaze® 0.4% (sodium hyaluronate 0.4%) preservative free eye drops have been added to the NHSGGC Adult Medicines Formulary following a Formulary appeal.

HEPMA Update – September 2022

Clinical trials of sodium-glucose co-transporter-2 inhibitors (SGLT2i) have demonstrated improvement in kidney and cardiovascular outcomes in patients with chronic kidney disease (CKD) with and without diabetes.

Guideline News August 2022

MHRA Drug Safety Update for August 2022

Key Medicine Shortages for August 2022

This post summarises the latest NHS Greater Glasgow and Clyde decisions relating to new medicines assessed by SMC and considered by the Area Drug and Therapeutics Committee (ADTC) and uses a nationally developed format specifically aimed for patients and the public.

For full details of the medicines included in this post that are available for use, including any restrictions on prescribing, please see the relevant entry in the GGC Formulary